Genotyping of Non-small Cell Lung Cancer
NCT02002117 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2014-07-30
Summary
The logical next step is to integrate molecular profiling into the care of all patients with NSCLC.
Conditions
- Non-small Cell Lung Cancer
- Gene Abnormality
Interventions
- OTHER
-
DNA mass
DNA mass spectrometry
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Chih-Hsin Yang, PhD
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2015-04-30
- Completion
- 2016-04-30
Countries
- Taiwan
Study Locations
More Related Trials
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
The Research Plan of Taiwan Precision Medicine
NCT04849481 ·Status: RECRUITING
-
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
NCT02422628 ·Status: UNKNOWN
-
Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications
NCT00260871 ·Status: UNKNOWN
-
The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer
NCT04018183 ·Status: COMPLETED
-
Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation
NCT06838806 ·Status: RECRUITING
-
Methylation Status of CD44 Promoter Region in Primary Lung Cancer
NCT00173680 ·Status: UNKNOWN
-
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients
NCT05023746 ·Status: COMPLETED
-
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00450281 ·Status: COMPLETED
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Develop and Test the Effects of the 'Computer-Assisted OPD COPSCCP on Early Stage Lung Cancer Patients
NCT04506359 ·Status: RECRUITING ·Phase: NA
-
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
NCT05541744 ·Status: RECRUITING
-
PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT
NCT05008796 ·Status: UNKNOWN
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
NCT00257179 ·Status: UNKNOWN
-
A Prospective, Observational Trial on the Diagnostic and Prognostic of LM
NCT02607605 ·Status: UNKNOWN
-
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC
NCT00797238 ·Status: UNKNOWN
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer
NCT01078883 ·Status: UNKNOWN
-
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
NCT04266691 ·Status: COMPLETED